Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Giovanni Baraldi

Showing results (91-100 of 159) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry|December 14, 2007
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Delia Preti, et al.
European Journal of Medicinal Chemistry|February 29, 2016
Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Emanuela Ruggiero, et al.
Journal of Medicinal Chemistry|June 23, 2006
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agentsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Giovanna Pavani, et al.
Journal of Medicinal Chemistry|March 21, 2003
Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonistsPier Giovanni Baraldi, Francesca Fruttarolo, Mojgan Aghazadeh Tabrizi, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Synthesis, radiolabeling, and preliminary biological evaluation of [3H]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl)-piperazine, a potent antagonist radioligand for the P2X7 receptorRomeo Romagnoli, Pier Giovanni Baraldi, Maria Giovanna Pavani, et al.
Bioorganic & Medicinal Chemistry|February 20, 2007
N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptorPier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Journal of Medicinal Chemistry|April 28, 2010
Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analoguesRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Journal of Medicinal Chemistry|January 29, 2013
Design, synthesis, and pharmacological properties of new heteroarylpyridine/heteroarylpyrimidine derivatives as CB(2) cannabinoid receptor partial agonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Giulia Saponaro, et al.
European Journal of Medicinal Chemistry|April 19, 2017
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agentsRomeo Romagnoli, Pier Giovanni Baraldi, Filippo Prencipe, et al.
European Journal of Medicinal Chemistry|July 5, 2015
Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect studyRomeo Romagnoli, Pier Giovanni Baraldi, Carlota Lopez-Cara, et al.
Pageof 16

Showing results (91-100 of 159) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry|December 14, 2007
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Delia Preti, et al.
European Journal of Medicinal Chemistry|February 29, 2016
Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Emanuela Ruggiero, et al.
Journal of Medicinal Chemistry|June 23, 2006
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agentsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Giovanna Pavani, et al.
Journal of Medicinal Chemistry|March 21, 2003
Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonistsPier Giovanni Baraldi, Francesca Fruttarolo, Mojgan Aghazadeh Tabrizi, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Synthesis, radiolabeling, and preliminary biological evaluation of [3H]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl)-piperazine, a potent antagonist radioligand for the P2X7 receptorRomeo Romagnoli, Pier Giovanni Baraldi, Maria Giovanna Pavani, et al.
Bioorganic & Medicinal Chemistry|February 20, 2007
N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptorPier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Journal of Medicinal Chemistry|April 28, 2010
Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analoguesRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Journal of Medicinal Chemistry|January 29, 2013
Design, synthesis, and pharmacological properties of new heteroarylpyridine/heteroarylpyrimidine derivatives as CB(2) cannabinoid receptor partial agonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Giulia Saponaro, et al.
European Journal of Medicinal Chemistry|April 19, 2017
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agentsRomeo Romagnoli, Pier Giovanni Baraldi, Filippo Prencipe, et al.
European Journal of Medicinal Chemistry|July 5, 2015
Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect studyRomeo Romagnoli, Pier Giovanni Baraldi, Carlota Lopez-Cara, et al.
Pageof 16